# Crossover Trial of AD182 and AD504 in Obstructive Sleep Apnea

> **NCT04645524** · PHASE2 · COMPLETED · sponsor: **Apnimed** · enrollment: 15 (actual)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DRUG:** AD182
- **DRUG:** AD504
- **DRUG:** Placebo
- **DIAGNOSTIC_TEST:** Polysomnography

## Key facts

- **NCT ID:** NCT04645524
- **Lead sponsor:** Apnimed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-01
- **Primary completion:** 2021-09-01
- **Final completion:** 2021-09-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2022-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04645524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04645524, "Crossover Trial of AD182 and AD504 in Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04645524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*